Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al.
2010-09-10 • AIDS
2010-09-10 • AIDS
OBJECTIVE: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, ...
Cornell M, Technau KG, Fairall L, Wood R, Moultrie H, et al.
2009-09-01 • South African Medical Journal
2009-09-01 • South African Medical Journal
OBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South...
Lawn SD, Campbell L, Kaplan R, Boulle AM, Cornell M, et al.
2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
We studied the time interval between starting tuberculosis treatment and commencing antiretroviral treatment (ART) in HIV-infected patients (n = 1433; median CD4 count 71 cells per micro...
Cassidy T, Cornell M, Runeyi P, Dutyulwa T, Kilani C, et al.
2022-01-25 • Journal of the International AIDS Society
2022-01-25 • Journal of the International AIDS Society
INTRODUCTION Youth living with HIV (YLWH) are less likely to initiate antiretroviral therapy (ART) and remain in care than older adults. It is important to identify effective strate...
Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, et al.
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND: Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in chi...
Johnson LF, Mossong J, Dorrington R, Schomaker M, Hoffman CJ, et al.
2013-04-09 • PLOS Medicine
2013-04-09 • PLOS Medicine
Few estimates exist of the life expectancy of HIV-positive adults receiving antiretroviral treatment (ART) in low- and middle-income countries. We aimed to estimate the life expectancy o...
2020-05-14 • Journal of the International AIDS Society
2020-05-14 • Journal of the International AIDS Society
Introduction
In South Africa, an estimated 4.6 million people were accessing antiretroviral therapy (ART) in 2018. As universal Test and Treat is implemented, these numbers will con...
Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, et al.
2012-09-04 • PLOS Medicine
2012-09-04 • PLOS Medicine
Background: Increased mortality among men on antiretroviral therapy (ART) has been documented but remains poorly understood. We examined the magnitude of and risk factors for g...
Cornell M, Johnson LF, Schomaker M, Tanser F, Maskew M, et al.
2015-08-03 • Lancet HIV
2015-08-03 • Lancet HIV
BACKGROUND As access to antiretroviral therapy (ART) expands, increasing numbers of older patients will start treatment and need specialised long-term care. However, the effect of ag...
Nyakato P, Schomaker M, Sipambo N, Technau KG, Fatti G, et al.
2021-01-21 • AIDS
2021-01-21 • AIDS
Background and objectives:
Adolescents living with perinatally acquired HIV (ALPHIV) on antiretroviral therapy (ART) have been noted to have poorer adherence, retention and virolog...
Osler M, Cornell M, Ford NP, Hilderbrand K, Goemaere E, et al.
2020-06-26 • Journal of the International AIDS Society
2020-06-26 • Journal of the International AIDS Society
INTRODUCTION Few studies have systematically described population‐level differences comparing men and women across the continuum of routine HIV care. This study quantifies differenti...
Nyakato P, Schomaker M, Fatti G, Tanser F, Euvrard J, et al.
2022-01-15 • Journal of the International AIDS Society
2022-01-15 • Journal of the International AIDS Society
INTRODUCTION Older adolescents aged 15-19 years continue to have high rates of loss to follow up (LTFU), and high rates of virologic non-suppression (VNS) compared to younger adolesc...
Cassidy T, Cornell M, Makeleni B, Horsburgh CR, Trivino Duran L, et al.
2022-07-31 • AIDS and Behavior
2022-07-31 • AIDS and Behavior
Men have higher rates of attrition from antiretroviral therapy (ART) programs than women. In Khayelitsha, a high HIV prevalence area in South Africa, two public sector primary healthcare...
